Sarepta Therapeutics Correlations

SRPT Stock

USD 75.90 0.00 0.00%

The correlation of Sarepta Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Sarepta Therapeutics Correlation With Market

Modest diversification

The correlation between Sarepta Therapeutics and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sarepta Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Sarepta Stock please use our How to Invest in Sarepta Therapeutics guide.

Moving together with Sarepta Stock

0.8	CDIOW	Cardio Diagnostics	Pair Corr
0.7	ELVN	Enliven Therapeutics	Pair Corr
0.8	SCLX	Scilex Holding	Pair Corr
0.85	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.62	CDIO	Cardio Diagnostics	Pair Corr
0.66	CMND	Clearmind Medicine Common	Pair Corr
0.67	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.62	CAT	Caterpillar	Pair Corr
0.65	HD	Home Depot	Pair Corr
0.71	DIS	Walt Disney	Pair Corr
0.78	MSFT	Microsoft	Pair Corr

Moving against Sarepta Stock

0.8	LUCD	Lucid Diagnostics	Pair Corr
0.72	WM	Waste Management	Pair Corr
0.63	GE	GE Aerospace	Pair Corr
0.41	PLX	Protalix Biotherapeutics	Pair Corr
0.39	PG	Procter Gamble	Pair Corr
0.81	JNJ	Johnson Johnson	Pair Corr
0.8	T	ATT Inc Earnings Call Today	Pair Corr
0.75	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.71	CVX	Chevron Corp Sell-off Trend	Pair Corr
0.65	MMM	3M Company	Pair Corr
0.63	INTC	Intel	Pair Corr
0.58	IBM	International Business	Pair Corr
0.42	CSCO	Cisco Systems	Pair Corr

Related Correlations Analysis

	RETA	MRTX	KRYS	ICPT	PTCT	IOVA	MDGL	VKTX	HEPA
RETA		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RETA
MRTX	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	MRTX
KRYS	0.0	0.0		0.0	0.84	-0.62	0.48	-0.43	-0.6	KRYS
ICPT	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	ICPT
PTCT	0.0	0.0	0.84	0.0		-0.8	0.64	-0.64	-0.79	PTCT
IOVA	0.0	0.0	-0.62	0.0	-0.8		-0.45	0.89	0.87	IOVA
MDGL	0.0	0.0	0.48	0.0	0.64	-0.45		-0.46	-0.63	MDGL
VKTX	0.0	0.0	-0.43	0.0	-0.64	0.89	-0.46		0.88	VKTX
HEPA	0.0	0.0	-0.6	0.0	-0.79	0.87	-0.63	0.88		HEPA
	RETA	MRTX	KRYS	ICPT	PTCT	IOVA	MDGL	VKTX	HEPA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VKTX	+ 0.89	IOVA
HEPA	+ 0.88	VKTX
HEPA	+ 0.87	IOVA
PTCT	+ 0.84	KRYS
MDGL	+ 0.64	PTCT
MDGL	+ 0.48	KRYS

High negative correlations

IOVA	- 0.8	PTCT
HEPA	- 0.79	PTCT
VKTX	- 0.64	PTCT
HEPA	- 0.63	MDGL
IOVA	- 0.62	KRYS
HEPA	- 0.6	KRYS

Risk-Adjusted Indicators

There is a big difference between Sarepta Stock performing well and Sarepta Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sarepta Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RETA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
KRYS	1.99	0.26	0.12	0.50	2.38	(2.17)	3.40	(3.84)	16.57
ICPT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PTCT	1.88	0.41	0.19	0.34	1.94	(2.11)	4.83	(3.32)	13.60
IOVA	2.98	(1.07)	0.00	(1.81)	0.00	0.00	4.31	(7.85)	24.66
MDGL	3.00	0.33	0.08	0.22	3.97	(3.01)	7.64	(5.66)	23.14
VKTX	3.69	(0.56)	0.00	(0.90)	0.00	0.00	8.39	(10.98)	24.65
HEPA	9.87	(3.91)	0.00	(5.38)	0.00	0.00	16.37	(31.39)	90.05

Sarepta Therapeutics Corporate Management

Ryan JD	General VP	Profile
Will Tilton	Head VP	Profile
Joseph Bratica	Controller VP	Profile
William Ciambrone	Ex Operations	Profile
Dallan Murray	Executive Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC